Obinutuzumab Treatment in Rituximab- and Bortezomib-Resistant Phospholipase A2 Receptor Antibody-Positive Membranous Nephropathy. [PDF]
CureusYildirim U, Ozkurt S, Yalcin AU.
europepmc +1 more source
Journal of Internal Medicine, Volume 300, Issue 3, Page 258-283, September 2026.Abstract Since 1858, human atherosclerotic plaques have been shown to contain immune cells. But are these cells suitable therapeutic targets? Dozens of clinical trials of anti‐inflammatory agents other than colchicine have been performed in patients with clinically evident atherosclerosis.
Kevin Jon Williams
wiley +1 more source
Endogenous "Time Bomb" - Mislocalized Phospholipase A2 as a Critical Mediator of Ultra-Rapid Mortality in Sepsis and Acute Lung Injury. [PDF]
Adv Sci (Weinh)Wang J +7 more
europepmc +1 more source
Anti-phospholipase A2 Receptor Membranous Nephropathy Presenting as Common Geriatric Complaints: A Case Report. [PDF]
CureusLi WTV, Wu KH, Lin OY.
europepmc +1 more source
Cytosolic phospholipase A2 links tau pathology to insulin signaling impairment in Alzheimer's disease. [PDF]
Front Aging NeurosciHossen F +4 more
europepmc +1 more source
Lipoprotein-associated phospholipase A2 and complications of diabetes mellitus: a systematic review and meta-analysis. [PDF]
Front Endocrinol (Lausanne)Guo S, Zhao X.
europepmc +1 more source
Identification of antibodies against phospholipase A2 receptor peptides in PLA2R-associated membranous nephropathy with negative circulating anti-PLA2R antibodies. [PDF]
Front ImmunolWang M +6 more
europepmc +1 more source
Role of protein kinase C in the release of arachidocic acid from platelets
, 1999 MACCHIONI, Lara +5 more
core
Cytosolic phospholipase A2 as a therapeutic target for degenerative joint diseases. [PDF]
Bone ResHuang G +6 more
europepmc +1 more source
A Catalytically Inactive Phospholipase A2 Homologue Facilitates Triacylglycerol-rich Lipoprotein Production in the Liver and Intestine. [PDF]
Cell Mol Gastroenterol HepatolSong S, Yen CE.
europepmc +1 more source